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Pseudo-hyperkalemia Obverted in a Patient with Kawasaki Disease during Treatments
Kei Sugimoto, Yukihide Chiba, Yoichiro Kaburaki,
Hirotaka Kaneko, Toshihisa Tsuruta, and Satoru Nagata
Department of Pediatrics, Tokyo Women’s Medical University, Tokyo, Japan
A 3-month-old girl was diagnosed with Kawasaki disease 4 days after onset and intravenous immunoglobulin
(IVIG) treatment was started on the same day. Because IVIG therapy was ineffective, a combination of IVIG and
prednisolone was administered on day 6. On day 9, the patient had hyperkalemia (6.5 mEq/L) without electrocar-
diographic abnormalities. The serum potassium level measured in blood collected in heparinized tubes was
within normal range. We diagnosed pseudohyperkalemia leading to leukocytosis and thrombocythemia, attribut-
able to coagulation system activation and increased release of potassium from leukocytes and/or platelets. Serum
potassium levels in patients with potential hyperkalemia under these conditions may require greater considera-
tion.
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緒 言
一般に偽性高カリウム（K）血症は，「血清 K値が
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Figure　1　Clinical course.
Although we started treating the urinary tract infection from the first hospital day, 5 of 
the 6 symptoms of Kawasaki disease (ocular conjunctival congestion, redness of the oro-
pharyngeal mucosa, irregular rash, rigid edema, neck lymphadenopathy) appeared on hos-
pital Day 4. Kawasaki disease was diagnosed on that day, and we therefore changed the 
treatment regimen. Because the first intravenous immunoglobulin (IVIG) administration 
was ineffective, combination therapy with IVIG and prednisolone was performed from Day 
6 onward. Although the symptoms of Kawasaki disease showed improvement, blood tests 
revealed hyperkalemia on Day 9．
KD, Kawasaki disease; ASA, Acetylsalicylic acid; GPC, Gram positive coccus; CTX, cefo-
taxime; ABPC, ampicillin; PSL, prednisolone; IVIG, intravenous immunoglobulin.
Table　1　Laboratory findings (Day1 L/D).
Complete blood count Biochemical tests Urinalysis
WBC 22,470 /μL AST 40 U/L Specific gravity 1.006
Neut 62.6 % ALT 25 U/L pH 5.5
Lym 29.7 % LD 291 U/L Protein qualitative ―
RBC 3.58×106 /μL BUN 4.6 mg/dL Sugar qualitative ―
Hb 10.0 g/dL Cr 0.23 mg/dL Occult blood ±
PLT 4.87×105 /μL Na 137 mEq/L RBC 1/1-4HF
K 5.2 mEq/L WBC 1/1-4HF
CI 103 mEq/L Microorganisms ±







体重 6.1 kg（＋0.2 SD），頭囲 39.1 cm（－0.3 SD），胸
囲 40.7 cm（＋0.5 SD）と体格は年齢相当であった．

















Figure　2　Correlation of white blood cell and platelet counts with serum potassium level.
This table shows the changes in white blood cell counts, platelet counts, and potassium (K) 
levels in peripheral blood. The normal upper limit of K is indicated by a dotted line. The 
tripartite values rise significantly through Day 9．
WBC, White blood cells; K, Potassium; PLT, Plateletes thrombocytes.
Table　2　Laboratory findings (Day9 L/D).
Complete blood count Biochemical tests
WBC 21,880 /μL AST 24 U/L
Neut 55.6 % ALT 12 U/L
Lym 38.3 % LDH 304 U/L
RBC 3.07×106 /μL BUN 6.8 mg/dL
Hb 9.0 g/dL Cr 0.2 mg/dL


































では，大気圧条件下で pH 7.45，PCO2 34.2 mmHg，




27 mg/dl，Cr 12 mg/dL，尿中 β2MG（macroglobu-
lin）220 μg/L（基準値：≦230 μg/L），浸透圧 312
mOsm/Kg・H2Oであった．この事より，急性腎不全
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Figure　3　Electrocardiographic findings Day 9.
Electrocardiography revealed a heart rate of 168 bpm, si-
nus rhythm, no significant ST-T change, and no significant




ロ ン 作 用 の 評 価 値 Transtubular K gradient
（TTKG）は 4.06で 10未満，腎臓での Kの排出機能










































































Figure　4　Hypothetical mechanism underlying development of pseudo-hyperkalemia.
When collected blood is injected into a test tube, leukocytes and platelets tend to contract. 
As a result, the potassium (K) in the blood cells is released into serum in the test tube lead-
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